Oramed Stock Based Compensation from 2010 to 2026

ORMP Stock  USD 3.18  0.07  2.15%   
Oramed Pharmaceuticals Stock Based Compensation yearly trend continues to be relatively stable with very little volatility. Stock Based Compensation is likely to grow to about 4.9 M this year. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals
 
Stock Based Compensation  
First Reported
2006-12-31
Previous Quarter
800 K
Current Value
719 K
Quarterly Volatility
12.4 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Oramed Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oramed Pharmaceuticals' main balance sheet or income statement drivers, such as Selling General Administrative of 7.8 M, Other Operating Expenses of 10.8 M or Research Development of 7.6 M, as well as many indicators such as Price To Sales Ratio of 74.82, Dividend Yield of 0.0 or PTB Ratio of 0.64. Oramed financial statements analysis is a perfect complement when working with Oramed Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Oramed Stock
Check out the analysis of Oramed Pharmaceuticals Correlation against competitors.
To learn how to invest in Oramed Stock, please use our How to Invest in Oramed Pharmaceuticals guide.
Evaluating Oramed Pharmaceuticals's Stock Based Compensation across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Oramed Pharmaceuticals's fundamental strength.

Latest Oramed Pharmaceuticals' Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Oramed Pharmaceuticals over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Oramed Pharmaceuticals' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oramed Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation10 Years Trend
Slightly volatile
   Stock Based Compensation   
       Timeline  

Oramed Stock Based Compensation Regression Statistics

Arithmetic Mean2,467,109
Geometric Mean1,480,813
Coefficient Of Variation114.37
Mean Deviation2,026,035
Median1,468,000
Standard Deviation2,821,593
Sample Variance8T
Range11.2M
R-Value0.64
Mean Square Error5T
R-Squared0.42
Significance0.01
Slope360,063
Total Sum of Squares127.4T

Oramed Stock Based Compensation History

20264.9 M
20254.7 M
20244.1 M
20234.2 M
202211.5 M
20212.7 M
2020465 K

Other Fundumenentals of Oramed Pharmaceuticals

Oramed Pharmaceuticals Stock Based Compensation component correlations

-0.940.450.970.99-0.50.40.990.370.910.020.250.960.580.980.95-0.56
-0.94-0.5-0.97-0.940.5-0.45-0.96-0.33-0.88-0.09-0.43-0.89-0.5-0.91-0.90.42
0.45-0.50.450.580.360.120.470.880.640.190.380.570.850.390.290.04
0.97-0.970.450.96-0.560.460.980.30.860.020.420.910.510.930.91-0.57
0.99-0.940.580.96-0.390.390.990.490.940.050.30.980.670.950.91-0.5
-0.50.50.36-0.56-0.39-0.56-0.460.53-0.130.03-0.34-0.320.33-0.51-0.560.39
0.4-0.450.120.460.39-0.560.38-0.130.220.20.510.29-0.120.340.370.02
0.99-0.960.470.980.99-0.460.380.380.930.020.260.960.580.970.95-0.56
0.37-0.330.880.30.490.53-0.130.380.590.09-0.050.560.950.340.230.08
0.91-0.880.640.860.94-0.130.220.930.590.050.150.930.730.880.86-0.44
0.02-0.090.190.020.050.030.20.020.090.050.180.030.020.010.030.28
0.25-0.430.380.420.3-0.340.510.26-0.050.150.180.120.020.140.1-0.21
0.96-0.890.570.910.98-0.320.290.960.560.930.030.120.720.970.92-0.42
0.58-0.50.850.510.670.33-0.120.580.950.730.020.020.720.540.42-0.2
0.98-0.910.390.930.95-0.510.340.970.340.880.010.140.970.540.98-0.52
0.95-0.90.290.910.91-0.560.370.950.230.860.030.10.920.420.98-0.46
-0.560.420.04-0.57-0.50.390.02-0.560.08-0.440.28-0.21-0.42-0.2-0.52-0.46
Click cells to compare fundamentals

About Oramed Pharmaceuticals Financial Statements

Oramed Pharmaceuticals shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Oramed Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Oramed Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Oramed Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Stock Based Compensation4.7 M4.9 M
Stock Based Compensation To Revenue 0.20  0.19 

Pair Trading with Oramed Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oramed Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Oramed Stock

  0.86JNJ Johnson JohnsonPairCorr
  0.64PFE Pfizer Inc Aggressive PushPairCorr
  0.89LPCN LipocinePairCorr

Moving against Oramed Stock

  0.84HPQ HP IncPairCorr
  0.72MSFT MicrosoftPairCorr
  0.56BRK-A Berkshire HathawayPairCorr
  0.31MMM 3M CompanyPairCorr
The ability to find closely correlated positions to Oramed Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oramed Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oramed Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oramed Pharmaceuticals to buy it.
The correlation of Oramed Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oramed Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oramed Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oramed Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Oramed Stock Analysis

When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.